Product Safety Recalls

Product Recall Tracker

ZONISAMIDE Recall D-0791-2022

Description: Zonisamide Capsules USP, 25 mg, packaged in 100-count bottles, Rx Only, Manufactured by: Glenmark Pharmaceuticals, Inc., USA Monroe, NC 28110, Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430, NDC 68462-128-01

ZONISAMIDE Recall D-0791-2022 Information

StatusOngoing
Mandated?Voluntary: Firm initiated
Recall NumberD-0791-2022
Event ID90029
BrandZONISAMIDE
Generic NameZONISAMIDE
ManufacturerZONISAMIDE
Original Package?1
Active SubstanceZONISAMIDE
Drug RouteORAL
DistributionUSA nationwide
Quantity11,136 bottles
Recall ReasoncGMP deviations
Drug ClassificationClass II
Drug Code Info20220504
Product NDC68462-128 68462-129 68462-130
Product NUIN0000175753 N0000008486 M0020790
Drug UPC0368462130018 0368462128015 0368462129012
Pharma Class (PE)Decreased Central Nervous System Disorganized Electrical Activity [PE]
Pharma Class (EPC)Anti-epileptic Agent [EPC]
Pharma Class (CS)Sulfonamides [CS]
Recall Initiation Date20220425
Report Date20220504
Classification Date20220427
Address750 Corporate Dr
Mahwah, NJ 07430-2009
United States
Recalling FirmGlenmark Pharmaceuticals Inc., USA
Initial Notification Letter
Unique Ingredient Identifier459384H98V
Drug Application NumberANDA077651
Structured Product Labeling (SPL ID)5c503c30-821e-410a-abf7-bd15bb358c11
Structured Product Labeling (SPL Set ID)fe15e56e-8b86-4a65-825c-31d37dd81612
Similar To

© 2021 Recall.Report / Contact / Privacy Policy

This site's data is aggregated programmatically and provided "as is" without any representations or warranties, express or implied.
Recall.report is not affiliated with the Consumer Product Safety Commision, FDA, or US government in any way.